Scientific publications for BioPredictive non-invasive diagnostics

Peer-reviewed studies validating BioPredictive blood-test diagnostics for liver disease — from first-in-class development cohorts to long-term meta-analyses.

34/433 Publications

Review Clear all

  1. Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub-Saharan Africa: Systematic review and meta-analysis. Review

    Surial B et al. · Liver Int · 2021

    FibroTest HBV

  2. The non-invasive assessment of hepatic fibrosis.

    Gheorghe G et al. · J Formos Med Assoc · 2021

    ActiTest FibroTest Alcohol HBV +2

  3. Non-invasive diagnosis and biomarkers in alcohol-related liver disease. Review

    Moreno C et al. · J Hepatol · 2019

    FibroTest Alcohol

  4. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers.

    Vilar-Gomez E et al. · J Hepatol · 2018

    FibroTest Metabolic

  5. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

    Terrault NA et al. · Hepatology · 2018

    ActiTest FibroTest HBV

  6. Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection.

    Parikh P et al. · Ann Transl Med · 2017

    FibroTest HBV

  7. Late presentation of chronic viral hepatitis for medical care: a consensus definition.

    Mauss S et al. · BMC Med · 2017

    FibroTest HBV HCV

  8. Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action. Review

    Bril F et al. · Diabetes Care · 2017

    FibroTest Metabolic

  9. Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review.

    Harris R et al. · Lancet Gastroenterol Hepatol · 2017

    FibroTest Other

  10. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis.

    Golabi P et al. · Expert Rev Gastroenterol Hepatol · 2016

    FibroTest Metabolic

  11. Management of the patient with SVR. Review

    Terrault NA et al. · J Hepatol · 2016

    FibroTest HCV

  12. Current Possibilities to Assess the Degree of Liver Fibrosis in Patients with Haemophilia Infected with HCV--Review.

    Kucharska M et al. · Adv Clin Exp Med · 2015

    FibroTest HCV

  13. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease.

    Lombardi R et al. · World J Gastroenterol · 2015

    FibroTest Alcohol

  14. Personalized management of cirrhosis by non-invasive tests of liver fibrosis.

    Wong GL et al. · Clin Mol Hepatol · 2015

    FibroTest Alcohol HBV HCV +1

  15. Transient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis.

    Brener S · Ont Health Technol Assess Ser · 2015

    Elasto-FibroTest FibroTest Alcohol HBV +3

  16. Hepatitis B: are non-invasive markers of liver fibrosis reliable?

    Castera L · Liver Int · 2014

    FibroTest HBV HCV

  17. Liver fibrosis markers in alcoholic liver disease.

    Chrostek L et al. · World J Gastroenterol · 2014

    FibroTest Alcohol

  18. Non-invasive diagnosis of hepatitis B virus-related cirrhosis.

    Lee S et al. · World J Gastroenterol · 2014

    FibroTest HBV

  19. [The value of noninvasive serological markers in hepatitis B].

    García-Samaniego J et al. · Gastroenterol Hepatol · 2014

    FibroTest HBV

  20. Noninvasive evaluation of NAFLD.

    Castera L et al. · Nat Rev Gastroenterol Hepatol · 2013

    ActiTest FibroTest NashTest SteatoTest +1

  21. Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.

    Festi D et al. · Aliment Pharmacol Ther · 2013

    SteatoTest

  22. The new paradigm of hepatitis C therapy: integration of oral therapies into best practices.

    Afdhal NH et al. · J Viral Hepat · 2013

    ActiTest FibroTest HCV

  23. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.

    European Association For The Study Of The Liver · J Hepatol · 2012

    ActiTest FibroTest HBV

  24. Non-invasive evaluation of liver fibrosis in chronic hepatitis C.

    Trifan A et al. · Rev Med Chir Soc Med Nat Iasi · 2012

    FibroTest HCV

  25. First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy.

    Poynard T · J Hepatol · 2011

    ActiTest AshTest FibroTest NashTest +7

  26. Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity.

    Montaudié H et al. · J Eur Acad Dermatol Venereol · 2011

    FibroTest Other

  27. Non-invasive markers for hepatic fibrosis.

    Baranova A et al. · BMC Gastroenterol · 2011

    FibroTest Alcohol HBV HCV +3

  28. Non-invasive assessment of liver fibrosis: are we ready?

    Castera L et al. · Lancet · 2010

    FibroTest Alcohol HBV HCV +1

  29. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Key publication

    Poynard T et al. · Gastroenterol Clin Biol · 2008

    ActiTest FibroTest SteatoTest Alcohol +5

  30. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience. Key publication

    Munteanu M et al. · J Gastrointestin Liver Dis · 2008

    ActiTest AshTest FibroTest NashTest +6

  31. FibroTest-FibroSURE: towards a universal biomarker of liver fibrosis?

    Poynard T et al. · Expert Rev Mol Diagn · 2005

    ActiTest FibroTest Alcohol HBV +2

  32. Acoustic Radiation Force Impulse Imaging for Diagnosis and Monitoring of Liver Fibrosis in Patients with Hepatitis C: A review of diagnostic accuracy, clinical effectiveness,…

    FibroTest HCV

  33. Ministère des Affaires Sociales et de la Santé Key publication

    FibroTest HBV HCV

  34. Poynard T, Imbert-Bismut F, Ratziu V

    ActiTest FibroTest HBV HCV

Showing the full result list. The page is server-rendered and not paginated.